Lupin slips 5%, nears 52-week low post December quarter results

 
 Shares of Lupin dipped 5 per cent to Rs 859.50 on the BSE
Lupin
Lupin, Glenmark shift focus to inhalation and nasal Covid-19 drugs
Just after injectables and oral strong medicine, pharmaceutical corporations are focusing on coming up with